ILMN and LAB Related Headlines
Go Back- Standard BioTools completes $350 million SomaLogic sale to Illumina
- Standard BioTools Completes Sale of SomaLogic to Illumina
- Illumina reports 40 customers using protein prep solution across 16 sites
- Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks
- Illumina launches protein prep assay for drug discovery research
- Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
- Illumina (ILMN) to acquire SomaLogic
- Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy
- Standard BioTools (LAB) Sells SomaLogic to Illumina (ILMN)
- Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina
ILMN and LAB Related Press Releases
Go Back- Standard BioTools Completes Sale of SomaLogic to Illumina
- Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks
- Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
- Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy
- Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina
